<?xml version='1.0' encoding='utf-8'?>
<document id="18675768"><sentence text="Adverse effects of propafenone after long-term therapy with the addition of citalopram."><entity charOffset="19-30" id="DDI-PubMed.18675768.s1.e0" text="propafenone" /><entity charOffset="76-86" id="DDI-PubMed.18675768.s1.e1" text="citalopram" /><pair ddi="false" e1="DDI-PubMed.18675768.s1.e0" e2="DDI-PubMed.18675768.s1.e0" /><pair ddi="false" e1="DDI-PubMed.18675768.s1.e0" e2="DDI-PubMed.18675768.s1.e1" /></sentence><sentence text="Propafenone, a class IC antiarrhythmic, and citalopram, a selective serotonin reuptake inhibitor (SSRI), are widely used in older patients"><entity charOffset="0-11" id="DDI-PubMed.18675768.s2.e0" text="Propafenone" /><entity charOffset="44-54" id="DDI-PubMed.18675768.s2.e1" text="citalopram" /><entity charOffset="68-77" id="DDI-PubMed.18675768.s2.e2" text="serotonin" /><pair ddi="false" e1="DDI-PubMed.18675768.s2.e0" e2="DDI-PubMed.18675768.s2.e0" /><pair ddi="false" e1="DDI-PubMed.18675768.s2.e0" e2="DDI-PubMed.18675768.s2.e1" /><pair ddi="false" e1="DDI-PubMed.18675768.s2.e0" e2="DDI-PubMed.18675768.s2.e2" /><pair ddi="false" e1="DDI-PubMed.18675768.s2.e1" e2="DDI-PubMed.18675768.s2.e1" /><pair ddi="false" e1="DDI-PubMed.18675768.s2.e1" e2="DDI-PubMed.18675768.s2.e2" /></sentence><sentence text=" Although a potential interaction between propafenone and SSRIs has been noted, a MEDLINE search revealed no published reports of an interaction between propafenone and citalopram"><entity charOffset="42-53" id="DDI-PubMed.18675768.s3.e0" text="propafenone" /><entity charOffset="153-164" id="DDI-PubMed.18675768.s3.e1" text="propafenone" /><entity charOffset="169-179" id="DDI-PubMed.18675768.s3.e2" text="citalopram" /><pair ddi="false" e1="DDI-PubMed.18675768.s3.e0" e2="DDI-PubMed.18675768.s3.e0" /><pair ddi="false" e1="DDI-PubMed.18675768.s3.e0" e2="DDI-PubMed.18675768.s3.e1" /><pair ddi="false" e1="DDI-PubMed.18675768.s3.e0" e2="DDI-PubMed.18675768.s3.e2" /><pair ddi="false" e1="DDI-PubMed.18675768.s3.e1" e2="DDI-PubMed.18675768.s3.e1" /><pair ddi="false" e1="DDI-PubMed.18675768.s3.e1" e2="DDI-PubMed.18675768.s3.e2" /></sentence><sentence text="" /><sentence text="The goal of this article was to describe a potential drug-drug interaction between propafenone and citalopram, which caused symptoms of propafenone adverse effects"><entity charOffset="83-94" id="DDI-PubMed.18675768.s5.e0" text="propafenone" /><entity charOffset="99-109" id="DDI-PubMed.18675768.s5.e1" text="citalopram" /><entity charOffset="136-147" id="DDI-PubMed.18675768.s5.e2" text="propafenone" /><pair ddi="false" e1="DDI-PubMed.18675768.s5.e0" e2="DDI-PubMed.18675768.s5.e0" /><pair ddi="false" e1="DDI-PubMed.18675768.s5.e0" e2="DDI-PubMed.18675768.s5.e1" /><pair ddi="false" e1="DDI-PubMed.18675768.s5.e0" e2="DDI-PubMed.18675768.s5.e2" /><pair ddi="false" e1="DDI-PubMed.18675768.s5.e1" e2="DDI-PubMed.18675768.s5.e1" /><pair ddi="false" e1="DDI-PubMed.18675768.s5.e1" e2="DDI-PubMed.18675768.s5.e2" /></sentence><sentence text="" /><sentence text="An 80-year-old white female, followed up at the Memory Clinic for mild cognitive impairment, had been taking propafenone 900 mg/d for &gt;10 years for paroxysmal atrial fibrillation without adverse effects"><entity charOffset="109-120" id="DDI-PubMed.18675768.s7.e0" text="propafenone" /></sentence><sentence text=" Three months after starting citalopram, she experienced episodes of chest tightness and dizziness"><entity charOffset="29-39" id="DDI-PubMed.18675768.s8.e0" text="citalopram" /></sentence><sentence text=" The episodes became more frequent in the following months, causing several falls and requiring visits to the emergency department, but no acute coronary event was diagnosed" /><sentence text=" She was started on amlodipine 2"><entity charOffset="20-30" id="DDI-PubMed.18675768.s10.e0" text="amlodipine" /></sentence><sentence text="5 mg orally once daily, a nitroglycerin patch (0"><entity charOffset="26-39" id="DDI-PubMed.18675768.s11.e0" text="nitroglycerin" /></sentence><sentence text="4 mg/h), and warfarin 5 mg orally once daily" /><sentence text=" After one fall, the patient became delirious" /><sentence text=" Amlodipine and the nitroglycerin patch were discontinued and propafenone decreased to 450 mg/d; citalopram was continued at 20 mg/d"><entity charOffset="1-11" id="DDI-PubMed.18675768.s14.e0" text="Amlodipine" /><entity charOffset="20-33" id="DDI-PubMed.18675768.s14.e1" text="nitroglycerin" /><entity charOffset="62-73" id="DDI-PubMed.18675768.s14.e2" text="propafenone" /><entity charOffset="97-107" id="DDI-PubMed.18675768.s14.e3" text="citalopram" /><pair ddi="false" e1="DDI-PubMed.18675768.s14.e0" e2="DDI-PubMed.18675768.s14.e0" /><pair ddi="false" e1="DDI-PubMed.18675768.s14.e0" e2="DDI-PubMed.18675768.s14.e1" /><pair ddi="false" e1="DDI-PubMed.18675768.s14.e0" e2="DDI-PubMed.18675768.s14.e2" /><pair ddi="false" e1="DDI-PubMed.18675768.s14.e0" e2="DDI-PubMed.18675768.s14.e3" /><pair ddi="false" e1="DDI-PubMed.18675768.s14.e1" e2="DDI-PubMed.18675768.s14.e1" /><pair ddi="false" e1="DDI-PubMed.18675768.s14.e1" e2="DDI-PubMed.18675768.s14.e2" /><pair ddi="false" e1="DDI-PubMed.18675768.s14.e1" e2="DDI-PubMed.18675768.s14.e3" /><pair ddi="false" e1="DDI-PubMed.18675768.s14.e2" e2="DDI-PubMed.18675768.s14.e2" /><pair ddi="false" e1="DDI-PubMed.18675768.s14.e2" e2="DDI-PubMed.18675768.s14.e3" /></sentence><sentence text=" The patient recovered well, both cognitively and physically, and did not have any further symptoms in 1 year of follow-up" /><sentence text=" Results of coronary investigations were negative" /><sentence text="" /><sentence text="This is the first report of a possible interaction between propafenone and citalopram, which caused propafenone adverse effects (eg, dizziness, falls) and mimicked coronary artery disease"><entity charOffset="59-70" id="DDI-PubMed.18675768.s18.e0" text="propafenone" /><entity charOffset="75-85" id="DDI-PubMed.18675768.s18.e1" text="citalopram" /><entity charOffset="100-111" id="DDI-PubMed.18675768.s18.e2" text="propafenone" /><pair ddi="false" e1="DDI-PubMed.18675768.s18.e0" e2="DDI-PubMed.18675768.s18.e0" /><pair ddi="false" e1="DDI-PubMed.18675768.s18.e0" e2="DDI-PubMed.18675768.s18.e1" /><pair ddi="false" e1="DDI-PubMed.18675768.s18.e0" e2="DDI-PubMed.18675768.s18.e2" /><pair ddi="false" e1="DDI-PubMed.18675768.s18.e1" e2="DDI-PubMed.18675768.s18.e1" /><pair ddi="false" e1="DDI-PubMed.18675768.s18.e1" e2="DDI-PubMed.18675768.s18.e2" /></sentence><sentence text="" /></document>